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Abstract
Background: The association between periodontal conditions, oral yeast colonisation and salivary
proteins in subjects with type 2 diabetes (T2D) is not yet documented. The present study aimed
to assess the relationship between these variables in type 2 diabetic subjects with reference to
gender.
Methods: Fifty-eight type 2 diabetic subjects (23 males and 35 females) with random blood glucose
level ≥ 11.1 mmol/L were investigated. Periodontal conditions (plaque index [PI], bleeding on
probing [BOP], probing pocket depth [PD] (4 to 6 mm and ≥ 6 mm), oral yeasts, salivary
immunoglobulin (Ig) A, IgG and total protein concentrations, and number of present teeth were
determined.
Results: Periodontal conditions (PI [p < 0.00001], BOP [p < 0.01] and PD of 4 to 6 mm [p < 0.001],
salivary IgG (μg)/mg protein (p < 0.001) and salivary total protein concentrations (p < 0.05) were
higher in type 2 diabetic females with Candida albicans (C. albicans) colonisation compared to males
in the same group. Type 2 diabetic females with C. albicans colonisation had more teeth compared
to males in the same group (p < 0.0001).
Conclusion: Clinical and salivary parameters of periodontal inflammation (BOP and IgG (μg)/mg
protein) were higher in type 2 diabetic females with oral C. albicans colonisation compared to males
in the same group. Further studies are warranted to evaluate the association of gender with these
variables in subjects with T2D.
Background
There is a positive relationship between periodontal
inflammation and type 2 diabetes (T2D) [1]. Periodontal
inflammation has been shown to be higher in diabetic
individuals with random blood glucose level (RBGL) ≥
11.1 mmol/L compared to individuals with RBGL < 11.1
mmol/L [1]. However, it has been shown that there is no
difference in the periodontal status between diabetic sub-
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jects with RBGL) ≥ 11.1 mmol/L and non-diabetic indi-
viduals [1]. Oral Candida albicans (C. albicans)
colonisation is markedly increased in diabetic compared
with non-diabetic individuals and hyperglycemia seems
to play a significant role in this regard [2,3]. Diabetes is a
metabolic disease characterized by hyperglycemia due to
defects in insulin production, insulin action, or both. Dia-
betes mellitus can impair the function of polymorphonu-
clear leukocytes which may predispose diabetic patients
to greater risk of diseases including periodontal disease
and oral candidal infections [2]. There is an indistinct role
of oral yeasts in the etiology and pathogenesis of perio-
dontal inflammation, however; C. albicans has been iso-
lated from the oral cavities of individuals with severe
periodontal inflammation [4]. It has been reported that
oral  Candida  colonisation is significantly higher in
females compared to males; however, this relationship
remains debatable [5,6]. Recent studies have shown that
C. albicans can colonize the periodontal pockets and is sig-
nificantly associated with oral mucosal inflammation in
females [4,7].
Saliva plays a significant role in maintaining a healthy
oral environment. Approximately 95% of the salivary
immunoglobulin (Ig) A originates from the salivary gland
immunocytes, whereas, most IgG enters the oral cavity by
diffusing through the gingival crevices [8]. The concentra-
tion of IgG in saliva is normally low, approximately 20
mg/L; however, it is significantly increased in subjects
with periodontal inflammation [9,10]. Therefore, a raised
IgG concentration in saliva is expected to reflect periodon-
tal inflammation [10,11]. Increased levels of salivary IgA
and IgG have been reported in individuals with T2D [12].
Since there is an unclear association between periodontal
inflammation, oral yeast colonisation, T2D and gender,
the present study aimed to investigate the periodontal
conditions, oral yeasts colonization and salivary protein
profile in subjects with T2D with emphasis on gender.
Methods
The study was approved by the regional ethical review
board in Stockholm, Sweden and ethical committee of
Altamash Institute of Dental Medicine, Karachi, Pakistan.
Written information (consent form), printed in simple
English and Urdu (native language of Pakistan) was pro-
vided. Consenting individuals were invited to an oral
healthcare centre for a periodontal examination, collec-
tion of oral yeast and unstimulated whole saliva (UWS)
samples and measurement of RBGL.
Inclusion and exclusion criteria
Residents of the Punjab Colony, Karachi, Pakistan with
age ranging between 45 to 64 years were included in the
study [1,13]. Individuals with medically diagnosed T2D
and with a RBGL ≥ 11.1 mmol/L were included. It was
mandatory for the participants to have read/understood
and signed the consent form before being included in the
study.
"Smokers" were defined as individuals smoking at least
one cigarette daily for at least six months. Since smoking
and use of antibiotics, non-steroidal anti-inflammatory
drugs and steroids influence inflammation as well as oral
candidal colonisation, the individuals who admitted
these behaviours were excluded from the study [2,14,15].
Study population
A questionnaire survey was conducted in the Punjab col-
ony in which one thousand individuals were interviewed
[1,13]. Subjects who reported to have diabetes were
requested to present their medical records and/or pre-
scriptions, which confirmed their diabetes status. Among
the 1000 adults interviewed, 83 subjects reported to have
diabetes, out of which 79 subjects had medically diag-
nosed T2D. These 79 individuals were invited to an oral
healthcare centre for measurement of RBGL, collection of
oral yeast and saliva samples and evaluation of periodon-
tal status.
Fifty-eight consenting individuals (23 males and 35
females) satisfied the inclusion criteria and were admitted
to the study. There were no significant differences in age,
race, ethnicity, socioeconomic variables and living stand-
ards among the study population.
Measurement of random blood glucose levels
Individuals were instructed not to eat or drink at least two
hours before their RBGL was recorded. A glucometer
(ACCU CHEK, Advantage system/Sensor comfort strips,
Roche Diagnostics, Mannheim, Germany) was used to
record the RBGL which is a practical method to monitor
glycemic levels in individuals with pre-diagnosed diabetes
[16-19].
Collection of oral yeast samples
Participants were instructed to refrain from eating and
drinking at least two hours before collection of yeast sam-
ples. Sampling was performed between 10:00 am and
1:00 pm.
Each yeast sample was collected by scraping the dorsum of
the tongue with a sterile cotton swab (COPAN, Amies
Charcoal single swab, CE 0124, Italy). The swabs were
returned to the containment tube immediately after sam-
pling. Oral yeasts are pre-dominant on the dorsal surface
of tongue; therefore tongue surface scraping is a reliable
method for detecting Candida species [15].BMC Oral Health 2009, 9:12 http://www.biomedcentral.com/1472-6831/9/12
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Identification of oral yeast samples
Identification to species level was determined by a yeast
identification system (API 32-C System bioMériux yeast
identification programme, Lyon, France). If identification
was not possible with the API 32 system, the yeast isolate
was subjected to molecular identification.
For DNA isolation, yeast cells were suspended in 200 μl
sterile Polymerase Chain Reaction (PCR)-grade water and
genomic DNA was prepared using MagNA pure (Roche
Diagnostics GmbH, Mannheim, Germany) a DNA prepa-
ration robot [20]. For DNA sequencing and PCR analysis,
a region (about 500-bp) of 18S ribosomal ribonucleic
acid gene was amplified by PCR using universal primers
and ampliTaq Gold DNA polymarase. Primers and free
nucleotides from the PCR products were then removed by
using QIAquick PCR purification kit (250) (Qiagen,
GmbH, Hilden, Germany). The purified PCR products
were processed for DNA sequencing by BigDye Termina-
tor Cycle Sequencing using capillary electrophoresis tech-
nology in ABI 310 Genetic Analyzer (Applied Biosystems,
Foster City, CA). Both strands of PCR amplified DNA frag-
ments were sequenced to avoid error of sequencing [21].
The DNA sequence was analysed by a software and
searched in the Blast DNA database for yeast identifica-
tion and typing [22,23].
Collection of unstimulated whole saliva samples
The UWS samples were obtained immediately after collec-
tion of oral yeasts. To collect the UWS samples, the partic-
ipants were seated in a bent forward position on a
comfortable chair and instructed to spit for five continu-
ous minutes (without swallowing) into a clean plastic
funnel connected to a measuring cylinder [24,25]. The
volume of saliva was immediately measured and the sam-
ples were frozen in disposable 3.5 ml plastic tubes with lid
(Sarstedt, Lot: 4071801, Germany). All frozen samples
were sealed in an insulated box containing dry ice and
transferred to Karolinska University Hospital (Division of
Clinical Immunology) Huddinge, Sweden.
Determination of salivary IgG, IgA and total protein 
concentrations
Levels of salivary IgG, IgA and total protein concentration
were determined as described earlier [11]. In brief, micro-
titer plates (Corning Inc. NY, USA) were coated with 100
μl per well of anti-human IgG and anti-human IgA
(DAKO A/S, Denmark) in coating buffer (0.05 M carbon-
ate-bicarbonate buffer, pH 9.6) and incubated at room
temperature for 24 hours. After washing, 100 μL/well of
appropriately diluted IgG (Human serum protein calibra-
tor. DAKO A/S, Denmark) and IgA (human colostrum)
standards, positive control (saliva from a healthy subject),
negative control (saliva from IgA deficient adult subject)
and saliva samples were added to the respective micro-
plate wells. After incubation at room temperature, the
microplates were washed to remove unbound proteins.
Purified alkaline phosphatase conjugated anti-human IgG
and IgA (DAKO A/S IgA/AP, Denmark) were added (100
μL/well), and the microplates were incubated for three
hours at room temperature. After washing, 100 μL/well of
substrate (p-nitrophenyl phosphate) in 1.0 M dieth-
anolamine, 0.5 mM MgCl2, pH 9.8, (Sigma S-0942) was
added. The absorbance was read at 405 nm in a microtiter
plate photometer (Molecular devices, Vmax, Sunnyvale,
CA, U.S.A).
The bicinchoninic acid, (BCA™) Protein Assay Reagent Kit
(Product No. 23227, Pierce Chemical, Co., Rockford, IL,
USA), was used to determine the total protein concentra-
tion in the saliva supernatants. Using albumin as stand-
ard, aliquots of saliva (200 μL/well) were placed in
microtiter plates. The protein assay reagent was added,
and the plates were incubated at 37°C for 30 minutes.
Optical densities were read at 550 nm in a microtiter plate
photometer (Molecular devices, Vmax, Sunnyvale, CA,
U.S.A).
Periodontal examination, number of teeth and denture-
wearing
A full mouth plaque index (PI), bleeding on probing
(BOP) and probing pocket depth (PD) (4 to 6 mm and ≥
6 mm) were measured at four sites (mesial, distal, buccal
and palatal/lingual) of each tooth [1,26-28]. Individuals
were investigated for the number of present teeth (exclud-
ing maxillary and mandibular third molars) and use of
dentures. Teeth with only embedded root remnants were
considered as missing. A percentage of the numbers of
present teeth was also calculated by the following for-
mula:
Statistical analysis
The statistical analysis was performed using STATISTICA
v. 6.0, (Statsoft, Inc. 1984–2005, Tulsa, OK, USA). The sig-
nificance of differences of the dependent variables (Ig lev-
els, protein concentration, oral Candida  colonisation,
number of teeth and periodontal conditions) in type 2
diabetic individuals was determined using multiple logis-
tic regression. The independent variables were categorised
as dichotomous variables; for example, type 2 diabetic
males with C. albicans colonisation; 0 and type 2 diabetic
females with C. albicans colonisation; 1. For multiple
comparisons, Bonferroni Post Hoc test was performed.
Results
Study population
Out of the 58 participants, there were 29 subjects (17
males and 12 females) with C. albicans colonisation. In
() Number of present teeth ÷× 28 100BMC Oral Health 2009, 9:12 http://www.biomedcentral.com/1472-6831/9/12
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this group, the mean age of males and females was 50.5
years (range 45–64 years) and 49.3 years (range 45–59
years) respectively. In subjects without C. albicans coloni-
sation (n = 29), there were six males and 23 females. The
mean ages of males and females in this group were 50.6
years (range 45–56 years) and 51.1 years (range 47–59
years) correspondingly.
The durations of T2D in individuals with and without C.
albicans colonisation were 10.5 (range 8–14 years) and
10.8 years (range 8–12 years) correspondingly.
Oral yeast colonisation in subjects with T2D
Oral C. albicans colonisation was significantly higher in
type 2 diabetic males compared to females as shown in
Figure 1 (p < 0.01).
Prevalence of denture-wearing
In type 2 diabetic subjects with C. albicans colonisation,
denture-wearing was more frequent in males (47%) com-
pared to females (16.6%). There was no difference in den-
ture-wearing in type 2 diabetic subjects without C. albicans
colonisation (data not shown).
Salivary flow rate (SFR), salivary IgG (μg)/mg protein, IgA 
(μg)/mg protein and total protein concentration in relation 
to C. albicans colonisation, number of teeth and gender
Type 2 diabetic females had a lower SFR (mean 0.15 ml/
min; range 0.1–0.3 ml/min) compared to males with T2D
(mean 0.38 ml/min; range 0.2–0.5 ml/min) (p < 0.05).
Females with C. albicans colonisation had higher levels of
IgG (μg)/mg protein (p < 0.001) and total protein concen-
tration (p < 0.05) compared to males with C. albicans.
These results are shown in Figure 2 and Figure 3. The
females also had more teeth (mean number of teeth19.5;
range 13–21 teeth) compared with the males (mean
number of teeth 12; range 10–16 teeth) (p < 0.0001).
Among type 2 diabetic males and females without C. albi-
cans  colonisation, salivary IgG (μg)/mg protein levels
were 32.2 μg/mg (range 7–107.7 μg/mg) and 38.6 μg/mg
Oral Candida (C.) colonisation in relation to gender among type 2 diabetic subjects Figure 1
Oral Candida (C.) colonisation in relation to gender among type 2 diabetic subjects. † P < 0.01. Others (males): C. 
lusitaniae Others (females): C. kefyr. † Differences in oral Candida albicans (C. albicans) colonisation between type 2 diabetic 
males and females were tested using multiple logistic regression. For multiple comparisons, Bonferroni Post Hoc test was per-
formed.
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(range 2.8–79.3 μg/mg) correspondingly. In these sub-
jects, mean salivary IgA (μg)/mg protein levels were 364.9
μg/mg (range 155–1489 μg/mg) and 391.8 μg/mg (range
90–1863 μg/mg). Salivary total protein concentrations, in
these individuals, were 2181 mg/L (range 879.5–3812.3
mg/L) and 2569.4 mg/L (range 1914.8–3107.7 mg/L)
respectively.
Mean number of teeth in type 2 diabetic males and
females without C. albicans colonisation were 12.1 (range
9–15) and 15.6 teeth (range 9–16) respectively.
Periodontal conditions and number of teeth in relation to 
C. albicans colonisation and gender
Type 2 diabetic females with C. albicans colonisation had
higher PI (p < 0.00001), BOP (p < 0.01) and PD (4 to 6
mm) (p < 0.001) compared with males in the same group.
These females had more teeth (mean number of teeth
19.5; range 16 to 26) compared to type 2 diabetic males
with C. albicans colonisation (mean number of teeth 12;
range 10 to 16) (p < 0.0001). These results are shown in
Figure 4.
Discussion
Among non-diabetic individuals, C. albicans colonisation
has been reported to be higher in dentate females com-
pared to males [6]. The current study showed that clinical
and salivary parameters of periodontal inflammation
(BOP and IgG per milligram of the salivary total protein
concentration [IgG (μg)/mg protein]) are elevated in type
2 diabetic females with oral C. albicans colonisation com-
pared to males in the same group.
It is known that diabetic individuals have a reduced SFR
compared to non-diabetic controls and is independent of
glycemic levels [29,30]. In the present study, males and
females had similar casual plasma glucose levels; how-
ever, the SFR was almost twice as high in males compared
with females. An explanation that has been given in this
context is that the size of salivary glands is smaller in
females compared with males [31]. A raised salivary IgG
concentration has been reported in patients with T2D
[12]. It is noteworthy that a diminished SFR concentrates
the salivary proteins, thereby expressing raised concentra-
tions of salivary proteins including IgA and IgG. There-
Salivary IgG (μg)/mg protein and IgA (μg)/mg protein concentrations in type 2 diabetic subjects with and without oral C. albi- cans colonization in relation to gender Figure 2
Salivary IgG (μg)/mg protein and IgA (μg)/mg protein concentrations in type 2 diabetic subjects with and with-
out oral C. albicans colonization in relation to gender. # p < 0.001 indicates a higher concentration of salivary IgG (μg)/
mg protein concentration in type 2 diabetic females compared to males with T2D and oral C. albicans colonization. Differences 
in levels of salivary IgG (μg)/mg protein and IgA (μg)/mg protein in type 2 diabetic males and females with and without oral Can-
dida albicans (C. albicans) colonisation were tested using multiple logistic regression. Data are mean ± 2 standard deviations.
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fore, salivary IgA and IgG concentrations should be
expressed as IgA (μg)/mg protein and IgG (μg)/mg pro-
tein, to normalize against volume. An increased level of
salivary IgG (μg)/mg protein concentration reflects a
raised oral inflammation [11]. The intensity of periodon-
tal inflammation has been associated with the number of
teeth affected [32]. This reflects that a greater number of
teeth with inflamed periodontal tissues allow an extensive
leakage of IgG into the oral cavity through the gingival
crevices. In subjects with C. albicans colonisation, levels of
IgG (μg)/mg protein were almost twice as high in females
compared with males. However it is noteworthy that these
females had nearly twice as many teeth as males in the
same group. Therefore, among type 2 diabetic subjects
with C. albicans colonisation, the presence of more teeth
seems to be the most likely explanation for the higher IgG
(μg)/mg protein levels in females compared with males.
Other factors that may influence oral candidal colonisa-
tion include denture-wearing, xerostomia and age [33-
35]. In the current study, nearly 74% of the males were
harbouring oral C. albicans compared to 23% in females.
This is in accordance with another study where C. albicans
colonisation was dominant among males (83%) com-
pared to females (56%) [36]. It has been shown that oral
Candida colonisation can increase up to six-fold in den-
ture-wearers [37]. The current results showed that in sub-
jects with C. albicans colonisation, denture wearing was
more frequent in males (47%) compared to females
(16.6%). An explanation in this context may be that den-
tures (either partial or complete) obstruct the salivary flow
from minor salivary glands and the free exchange of oxy-
gen. Thus the resultant low pH level facilitates the growth
of C. albicans [37]. In the present study, among subjects
with  C. albicans colonisation, males had a higher SFR
compared to females. However, these flow rates were
lower than the SFR in non-diabetic individuals (0.5 ml/
min) [38]. It is known that there is an inverse relationship
between SFR and oral candidal colonisation. However;
despite having a higher SFR compared to the females,
males had increased C. albicans colonisation compared
with females. This may once again be associated with den-
ture-wearing which was approximately three times more
common in type 2 diabetic males (47%) compared to
females (16.6%) with T2D.
There is a positive relationship between C. albicans coloni-
sation and age [35]. However; in the current study age can
not be the effect on the differences in C. albicans colonisa-
tion, as it was adjusted in both groups.
The present results showed a higher PI, BOP and PD (4 to
6 mm) in females with C. albicans colonisation compared
to males. However, it is notable that these females had a
lower SFR and had approximately twice as many teeth as
males. Therefore, a higher number of teeth and reduced
SFR may possibly be associated with increased periodon-
tal conditions and salivary IgG (μg)/mg protein and total
protein concentration in these females compared with
males.
Salivary total protein concentrations in type 2 diabetic subjects with and without oral C. albicans colonisation in relation to gen- der Figure 3
Salivary total protein concentrations in type 2 diabetic subjects with and without oral C. albicans colonisation 
in relation to gender. * P < 0.05. Differences in salivary total protein concentrations in type 2 diabetic males and females 
with and without oral Candida albicans (C. albicans) colonisation were tested using multiple logistic regression. Data are mean ± 
2 standard deviations.
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Conclusion
Clinical and salivary parameters of periodontal inflamma-
tion (BOP and IgG (μg)/mg protein) were higher in type
2 diabetic females with oral C. albicans colonisation com-
pared to males in the same group. These gender-specific
features may offer a route to improve oral healthcare for
females with T2D. However, further studies are warranted
in this regard.
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